scispace - formally typeset
M

Mariana Brandão

Researcher at Université libre de Bruxelles

Publications -  84
Citations -  799

Mariana Brandão is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 9, co-authored 60 publications receiving 411 citations. Previous affiliations of Mariana Brandão include Instituto Português de Oncologia Francisco Gentil & Institut Jules Bordet.

Papers
More filters
Journal ArticleDOI

Treatment of advanced HER2-positive breast cancer: 2018 and beyond.

Noam Pondé, +4 more
- 02 May 2018 - 
TL;DR: Despite significant research efforts, including translational efforts and new imaging techniques, no predictive biomarkers have been clinically validated and therefore a more refined approach to treatment tailoring remains beyond the authors' reach.
Journal ArticleDOI

Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases.

Guillermo Barturen, +131 more
- 01 Jun 2021 - 
TL;DR: This study identified molecular clusters for reclassifying systemic autoimmune diseases independently of clinical diagnosis to identify molecular clusters defined by molecular pattern.
Journal ArticleDOI

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis

Evandro de Azambuja, +49 more
TL;DR: This population-based analysis demonstrates that solid cancer is an independent adverse prognostic factor for in-hospital mortality among patients with COVID-19, and patients with solid cancer should be prioritised in vaccination campaigns and in tailored containment measurements.
Journal ArticleDOI

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors.

Mariana Brandão, +3 more
- 01 Dec 2019 - 
TL;DR: Since the accuracy of current individual biomarkers is not optimal, a composite biomarker, including DNA, RNA and protein expression data, to more precisely assess the PI3K/AKT/mTOR pathway activation status, may arise as a promising approach.
Journal ArticleDOI

Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative.

Philippe Aftimos, +55 more
- 28 Jun 2021 - 
TL;DR: AURORA as discussed by the authors aims to study the processes of relapse in metastatic breast cancer (MBC) by performing multi-omics profiling on paired primary tumors and early-course metastases.